In HIV treatment, the barriers to care are numerous and complex, especially for those already marginalized by society. People living with HIV who also inject drugs face compounded stigma, which significantly impacts their ability to access and maintain healthcare. A recent study published in The Lancet Regional Health – Europe explored a novel intervention designed to address this critical issue by focusing on stigma coping mechanisms.
A team of researchers, including Jason Luoma PhD from Portland Psychotherapy, conducted a randomized clinical trial (RCT) in St. Petersburg, Russia, to assess the effectiveness of an acceptance-based, intersectional stigma coping intervention. This intervention was tailored for people living with HIV who inject drugs, aiming to mitigate the stigma-related barriers that often prevent them from seeking and adhering to necessary healthcare.
The Intervention
The study involved 100 participants who were living with HIV and had reported injection drug use within the past 30 days. These individuals were divided into two groups: one received standard harm reduction services, while the other participated in a three-session group intervention based on Acceptance and Commitment Therapy (ACT). The ACT sessions were designed to help participants accept and cope with the internalized, anticipated, and experienced stigma they face due to both their HIV status and drug use.
The intervention focused on empowering participants by encouraging them to accept stigma-related negativity without allowing it to dictate their actions. Instead of trying to change the stigmatizing attitudes directly, the therapy aimed to reduce the psychological link between these attitudes and the avoidance behaviors that often lead to disengagement from healthcare.
Key Findings
Although the intervention did not result in significant changes in self-reported stigma scores at one and six months post-intervention, the study revealed some promising outcomes. Participants who received the intervention were significantly more likely to initiate antiretroviral treatment (ART) and engage in substance use care compared to those who did not receive the intervention. Specifically, 20% of the intervention group initiated ART, compared to just 3% in the control group. Similarly, 23% of the intervention group sought substance use treatment, compared to only 6% of the control group.
These findings suggest that while the intervention may not have directly reduced internalized stigma, it did facilitate greater engagement with healthcare services. This outcome is crucial, as it highlights the potential of acceptance-based approaches to encourage health-seeking behaviors even in the face of pervasive societal stigma.
Implications for Future Research and Practice
The results of this study are particularly relevant in contexts where HIV and substance use stigma are deeply entrenched. The researchers suggest that future interventions might benefit from a multi-level approach that not only empowers individuals but also targets the structural and provider-level stigma that continues to hinder healthcare access.
The high satisfaction rates among participants and the fidelity with which the intervention was delivered underscore the feasibility of implementing such programs in real-world settings. As the study was conducted during the COVID-19 pandemic, the challenges faced by the participants—such as the disruption of healthcare services and increased isolation—may have influenced the results. Nonetheless, the fact that the intervention led to increased healthcare engagement despite these challenges is a testament to its potential effectiveness.
Conclusion
Stigma remains a significant barrier to healthcare for people living with HIV, particularly those who inject drugs. This study by a team of researchers, including experts from Portland Psychotherapy, offers valuable insights into how acceptance-based interventions can empower marginalized populations to overcome these barriers. While the intervention did not reduce stigma scores directly, it successfully encouraged participants to engage in essential healthcare services, marking an important step forward in the fight against HIV and substance use stigma.
As research in this area continues to evolve, the integration of stigma coping strategies with broader, systemic changes in healthcare delivery will be crucial. By addressing stigma at multiple levels, from individual coping strategies to institutional practices, we can work toward a more inclusive and effective healthcare system for all.
You can find an open access version of this article here.
Author: Portland Psychotherapy Team
